ABC Arbitrage SA Invests $1.57 Million in UnitedHealth Group Incorporated $UNH

ABC Arbitrage SA bought a new stake in UnitedHealth Group Incorporated (NYSE:UNH) during the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund bought 5,026 shares of the healthcare conglomerate’s stock, valued at approximately $1,568,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. HHM Wealth Advisors LLC boosted its holdings in shares of UnitedHealth Group by 0.9% during the 1st quarter. HHM Wealth Advisors LLC now owns 2,947 shares of the healthcare conglomerate’s stock worth $1,544,000 after buying an additional 26 shares in the last quarter. Brogan Financial Inc. boosted its stake in UnitedHealth Group by 3.4% during the first quarter. Brogan Financial Inc. now owns 819 shares of the healthcare conglomerate’s stock worth $429,000 after acquiring an additional 27 shares in the last quarter. West Wealth Group LLC increased its stake in UnitedHealth Group by 3.2% in the first quarter. West Wealth Group LLC now owns 882 shares of the healthcare conglomerate’s stock valued at $462,000 after purchasing an additional 27 shares in the last quarter. Hemington Wealth Management boosted its position in shares of UnitedHealth Group by 2.5% during the 1st quarter. Hemington Wealth Management now owns 1,154 shares of the healthcare conglomerate’s stock worth $604,000 after purchasing an additional 28 shares in the last quarter. Finally, Tlwm increased its position in UnitedHealth Group by 1.0% in the 1st quarter. Tlwm now owns 2,736 shares of the healthcare conglomerate’s stock valued at $1,433,000 after buying an additional 28 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Trading Up 3.6%

Shares of UNH stock opened at $339.18 on Thursday. UnitedHealth Group Incorporated has a 12-month low of $234.60 and a 12-month high of $622.83. The company has a quick ratio of 0.85, a current ratio of 0.82 and a debt-to-equity ratio of 0.71. The company has a 50 day moving average of $347.08 and a 200-day moving average of $320.66. The firm has a market cap of $307.25 billion, a P/E ratio of 17.70, a PEG ratio of 2.28 and a beta of 0.47.

UnitedHealth Group (NYSE:UNH) last released its earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. The business had revenue of $113.16 billion during the quarter, compared to the consensus estimate of $113.19 billion. UnitedHealth Group had a return on equity of 19.23% and a net margin of 4.04%.The business’s revenue for the quarter was up 12.2% on a year-over-year basis. During the same period last year, the business posted $7.15 earnings per share. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, December 16th. Investors of record on Monday, December 8th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.6%. The ex-dividend date is Monday, December 8th. UnitedHealth Group’s dividend payout ratio is presently 46.14%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have commented on the company. JPMorgan Chase & Co. raised their price objective on UnitedHealth Group from $310.00 to $425.00 and gave the company an “overweight” rating in a research note on Thursday, October 9th. Sanford C. Bernstein boosted their price target on shares of UnitedHealth Group from $433.00 to $440.00 and gave the company an “outperform” rating in a research note on Thursday, October 30th. Zacks Research upgraded shares of UnitedHealth Group from a “strong sell” rating to a “hold” rating in a report on Monday, October 6th. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a report on Thursday, July 31st. Finally, Robert W. Baird reissued an “underperform” rating and set a $198.00 price objective (down from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have issued a Sell rating to the stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.